During the past decade, Hugo W Moser Research Institute at Kennedy Krieger, Inc. conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hugo W Moser Research Institute at Kennedy Krieger, Inc." #1 sponsor was "Forest Laboratories" with 2 trials, followed by "Supernus Pharmaceuticals, Inc." with 2 trials sponsored, "Center for Psychological Consultation" with 1 trials sponsored, "Hugo W. Moser Research Institute at Kennedy Krieger, Inc." with 1 trials sponsored and "Kathryn Wagner" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hugo W Moser Research Institute at Kennedy Krieger, Inc." #1 collaborator was "Hugo W. Moser Research Institute at Kennedy Krieger, Inc." with 2 trials as a collaborator, "Child Mind Institute" with 1 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator, "Johns Hopkins University" with 1 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Hugo W Moser Research Institute at Kennedy Krieger, Inc." are "Attention Deficit Hyperactivity Disorder" (2 trials), "Major Depressive Disorder" (2 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (1 trials), "Child Development Disorder" (1 trials) and "Covid19" (1 trials). Many other conditions were trialed in "Hugo W Moser Research Institute at Kennedy Krieger, Inc." in a lesser frequency.

Most popular intervention types in "Hugo W Moser Research Institute at Kennedy Krieger, Inc." are "Drug" (6 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Vilazodone" (2 trials), "Best Message + Augmented Message or Implementation Strategy" (1 trials), "Best Message Alone" (1 trials) and "Dasotraline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hugo W Moser Research Institute at Kennedy Krieger, Inc." are 9 trials for "All" genders.

Currently, there are NaN active trials in "Hugo W Moser Research Institute at Kennedy Krieger, Inc.". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Hugo W Moser Research Institute at Kennedy Krieger, Inc., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hugo W Moser Research Institute at Kennedy Krieger, Inc., 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".